Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
24-Aug-15 Within two years of Vietnam's satellite hospital program, the rate of patients sent to central hospitals has declined sharply and several satellite hospitals are now performing advanced medical procedures. Khanh Hoa hospital’s director said heart patients in the province now have very little need to go to Ho Chi Minh City for treatment. [image: healthplus.vn]
Read More
23-Aug-15 Emerging-market sales for the big pharmaceuticals firms increased by about 5.5% year over year in the second quarter, well below the 9% average of the prior four quarters. Macroeconomic pressures are increasing. Weaker currencies hurt sales, a factor put into clear focus by China’s devaluation of the yuan. [image: Nai 500]
Read More
21-Aug-15 The Indian government plans to increase public investment in health from 1.04% of GDP to 2.5% by 2020. Approximately, 70% of the expenditure will be dedicated to primary health care. [image: The Richest]
Read More
26-Aug-15 China is aiming to control “wildly” growing stem cell therapy, issuing its first regulation covering the largely controversial medical procedure. “Only eligible hospitals can work with stem cells in clinical trials for research and there must not be fees or advertising,” said the National Health and Family Planning Commission. [image: Liu Haifeng / Xinhua Press / Corbis]
Read More
19-Aug-15 A new guideline allows foreign drugs to undergo clinical trials in their home country and in China at the same pace, speeding up approval procedures for new drugs that are badly needed in China. Clinical trials of new foreign drugs in China normally lag behind those in the home country. [image: Alamy / Daily Mail]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: